What should be done at this time?
1. Discontinue the amiodarone 2. Empiric antibiotics 3. Plasma brain naturetic peptide (BNP) 4. 1 and 3 5. All of the above
Correct! 3. Plasma brain naturetic peptide (BNP)
The chest x-ray shows small bilateral pleural effusions. The most common cause of bilateral pleural effusions is congestive heart failure. Given her clinical situation of having recent ventricular tachycardia this would be the most likely diagnosis (1) . Plasma brain naturetic peptide (BNP) is often elevated in these patients and can be useful if there is uncertainty about the diagnosis. Presentation of a pneumonia as bilateral pleural effusion is unlikely. Our patient's BNP was moderately elevated. Amiodarone has a number of pulmonary toxicities including bilateral pleural effusions on very rare occasions (2) . Amiodarone pulmonary toxicity usually manifests as an acute or subacute pneumonitis, typically with diffuse infiltrates on chest x-ray and high-resolution computed tomography. The risk benefit ratio was felt to favor continuing the amiodarone. She was discharged from the hospital on July 11th clinically doing well. The patient is an immunocompromised host aggressive pursuit of a diagnosis is appropriate. Given the right upper lobe density likely represents a pneumonia. Most advise bronchoscopy with bronchoalveolar lavage as an initial step (3). A coccidioidomycosis serology is appropriate given the frequency of Valley Fever in Arizona.
A bronchoscopy was performed which showed no endobronchial masses with areas of bronchial erythema (Figure 4) . Results of the bronchoalveolar lavage are shown in Table 1 . In addition, a urinary antigen for Legionella was negative. The patient was started on meropenem, levofloxacin, and fluconazole. She was continued on tacrolimus and amiodarone. However, she continued to have fever and repeat chest x-ray was performed two days after the bronchoscopy ( Figure 5 ). 
Correct! 5. Any of the above
Her chest x-ray shows worsening of her right lower lobe consolidation and a thoracic CT scan showed near complete consolidation of her upper right upper lobe with extension into the right middle and lower lobes. The cause of her pneumonia is unclear and it is not definitely clear how to proceed. Any of the options would probably be acceptable depending on local expertise and clinical judgment. Repeat bronchoscopy with bronchoalveolar lavage and transbronchial biopsy was offered to the patient. However, she was feeling slightly better and wanted to wait a few more days. Later that day the bronchoalveolar lavage polymerase chain reaction and culture both returned positive for Legionella. She was continued on her levofloxacin and made an uneventful recovery.
The mortality of Legionella is 16 to 30% but less than 10% with appropriate treatment (4). Azithromycin and levofloxacin both are both effective. There are no comparative studies but some suggest possible benefit from combined treatment. The duration of therapy is usually 10 to 14 days in immunocompetent patients and 21 days in immunosuppressed suppressed patients.
The urinary antigen for Legionella has a sensitivity of 80% and specificity close to 100%. The test is specific only for serogroup 1. However, the majority of Legionella in community-acquired pneumonia is serogroup 1.
Several signs and symptoms may be present in immuncompetent patients with community-acquired pneumonia suggesting Legionella (Table 2)   Table 2 . Signs and symptoms suggesting Legionella pneumonia.
 Presence of GI symptoms, especially diarrhea  Neurologic symptoms, especially confusion  Fever > 39º C.  Gram stain with white blood cells, few if any organisms  Hyponatremia  Hepatic dysfunction  Hematuria
